WILSON’S DISEASE TREATMENT MARKET ANALYSIS

Wilson’s Disease Treatment MarketSize and Trends

Global Wilson’s disease treatment market is estimated to be valued at US$ 527.0 million in 2022 and is expected to exhibit a CAGR of 6.2 % during the forecast period (2022-2030).

Figure 1.Global Wilson’s Disease Treatment Market Share (%) in Terms of Value, by Region, 2022

Rapid advancements in technology allowing for early diagnosis of Wilson’s disease is driving growth of the Wilson’s disease treatment market

Increasing advancement in techniques used for diagnosis of Wilson’s disease and it’s treatment has expected to drive the market growth over the forecast period. For instance, according to an article published by Translational Gastroenterology and Hepatology Journal in April 2021, several advances in diagnosis and genetic testing have proved to be helpful in early diagnosis to prevent long term complications of Wilson’s disease. Individuals with Wilson’s disease can be diagnosed using the clinical findings of Kayser Fleischer (KF) rings, cirrhosis, neurological, or mental problems like anxiety and depression in various combinations. Identification and quantification of Wilson’s disease has become easier due to recent advancement made in evaluating KF rings. A sensitive method for detection of KF rings by a non-ophthalmologist had been introduced in the anterior segment optical coherence tomography. Use of magnetic resonance (MR) spectroscopy of tissues in the pediatric population has severed as potential method for detecting early neurological involvement in pediatric patients with Wilson’s disease. One new method that has been recently discussed as capable diagnostic tool for Wilson’s disease diagnosis is liquid chromatography multiple reaction monitoring mass spectrometry.